-+ 0.00%
-+ 0.00%
-+ 0.00%

TVARDI THERAPEUTICS ADVANCES NEXT-GENERATION ORAL STAT3 INHIBITOR TTI-109 TOWARD IND IN INFLAMMATORY BOWEL DISEASE FOLLOWING FDA PRE-IND FEEDBACK

Reuters·11/19/2026 13:00:02

Please log in to view news